Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.
Innate is a pioneer in the understanding of natural killer cell biology and has expanded its
expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering.
This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Sanofi and AstraZeneca.
This booth and the information it contained do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to shares in Innate Pharma in any country.